blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1648440

EP1648440 - SEMI-SOLID FORMULATIONS FOR THE ORAL ADMINISTRATION OF TAXOIDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.01.2009
Database last updated on 11.09.2024
Most recent event   Tooltip12.11.2010Lapse of the patent in a contracting state
New state(s): GR		published on 15.12.2010  [2010/50]
Applicant(s)For all designated states
Aventis Pharma S.A.
20, avenue Raymond Aron
92160 Antony / FR
[2006/17]
Inventor(s)01 / BOROVAC, Tatiana
22 rue Sadi Carnot
F-92120 Montrouge / FR
02 / NEVES, Carole
13C avenue du Docteur Arnold Netter
F-75012 Paris / FR
03 / PERACCHIA, Maria-Teresa
18 rue Cuvier
F-75005 Paris / FR
 [2006/17]
Representative(s)Le Pennec, Magali, et al
Aventis Pharma S.A.
Direction des Brevets
Tri LEO/144
20 Avenue Raymond Aron
92165 Antony Cedex / FR
[N/P]
Former [2008/30]Le Pennec, Magali, et al
Aventis Pharma S.A. Direction des Brevets Tri LEO/144 20 Avenue Raymond Aron
92165 Antony Cedex / FR
Former [2006/17]Le Pennec, Magali, et al
Aventis Pharma S.A. Brevets 20, Avenue Raymond Aron
F-92165 Antony Cédex / FR
Application number, filing date04741331.515.07.2004
[2006/17]
WO2004EP08551
Priority number, dateEP2003029179518.07.2003         Original published format: EP 03291795
[2006/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005013968
Date:17.02.2005
Language:EN
[2005/07]
Type: A1 Application with search report 
No.:EP1648440
Date:26.04.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 17.02.2005 takes the place of the publication of the European patent application.
[2006/17]
Type: B1 Patent specification 
No.:EP1648440
Date:12.03.2008
Language:EN
[2008/11]
Search report(s)International search report - published on:EP17.02.2005
ClassificationIPC:A61K31/337, A61K9/48
[2006/17]
CPC:
A61K9/4858 (EP,US); A61K31/337 (EP,KR,US); A61K9/107 (KR);
A61K9/48 (KR); A61P35/00 (EP); A61K9/1075 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/17]
Extension statesAL20.02.2006
HR20.02.2006
LT20.02.2006
LV20.02.2006
MK20.02.2006
TitleGerman:HALBFESTE FORMULIERUNG FÜR DIE ORALE VERABREICHUNG DES TAXOLS[2006/17]
English:SEMI-SOLID FORMULATIONS FOR THE ORAL ADMINISTRATION OF TAXOIDS[2006/17]
French:FORMULATION SEMI-SOLIDE POUR L'ADMINISTRATION ORALE DU TAXOL[2006/17]
Entry into regional phase20.02.2006National basic fee paid 
20.02.2006Designation fee(s) paid 
20.02.2006Examination fee paid 
Examination procedure17.02.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.02.2006Examination requested  [2006/17]
31.05.2007Despatch of a communication from the examining division (Time limit: M04)
14.09.2007Reply to a communication from the examining division
17.12.2007Communication of intention to grant the patent
29.01.2008Fee for grant paid
29.01.2008Fee for publishing/printing paid
Opposition(s)15.12.2008No opposition filed within time limit [2009/08]
Fees paidRenewal fee
31.07.2006Renewal fee patent year 03
13.07.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY12.03.2008
CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
TR12.03.2008
BG12.06.2008
GR13.06.2008
LU15.07.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
HU13.09.2008
[2010/50]
Former [2010/38]CY12.03.2008
CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
TR12.03.2008
BG12.06.2008
LU15.07.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
HU13.09.2008
Former [2010/34]CY12.03.2008
CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
BG12.06.2008
LU15.07.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
HU13.09.2008
Former [2010/33]CY12.03.2008
CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
BG12.06.2008
LU15.07.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
Former [2009/44]CY12.03.2008
CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
BG12.06.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
Former [2009/30]CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
BG12.06.2008
CH31.07.2008
LI31.07.2008
MC31.07.2008
Former [2009/23]CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
BG12.06.2008
MC31.07.2008
Former [2009/22]CZ12.03.2008
EE12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
MC31.07.2008
Former [2009/18]CZ12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
MC31.07.2008
Former [2008/50]CZ12.03.2008
FI12.03.2008
PL12.03.2008
RO12.03.2008
SI12.03.2008
SK12.03.2008
Former [2008/44]FI12.03.2008
PL12.03.2008
SI12.03.2008
Former [2008/43]FI12.03.2008
PL12.03.2008
Former [2008/39]FI12.03.2008
Cited inInternational search[DXY]WO9949848  (RTP PHARMA INC [US]) [DX] 1-3,5-8 * page 4, line 27 * * page 7, line 18 - line 23 * * page 5, line 21 - line 27 * * examples 1-6 * * claims 1-21 * [Y] 4;
 [A]WO0130319  (SUPERGEN INC [US], et al) [A] 1-3,5-8 * examples 1-5 * * claims 1-5 *;
 [A]WO02064132  (UPJOHN CO [US], et al) [A] 1-3,5-8 * page 7, line 26 * * claims 1-8 *;
 [A]WO03045357  (TRANSFORM PHARMACEUTICALS INC [US], et al) [A] 1-8 * claims 1,19 * * page 27, line 9 *;
 [PX]WO03074027  (NOVAGALI SAS [FR], et al) [PX] 1-8 * claims 1-21 ** page 6, line 26 - line 27 *;
 [Y]  - MU L ET AL, "A novel controlled release formulation for the anticancer drug paclitaxel (Taxol<(>R)): PLGA nanoparticles containing vitamin E TPGS", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (20030109), vol. 86, no. 1, ISSN 0168-3659, pages 33 - 48, XP004398997 [Y] 1-8 * abstract * * page 34, column 2, line 32 - line 35 * * page 36, column 1, paragraph 2.4 *

DOI:   http://dx.doi.org/10.1016/S0168-3659(02)00320-6
 [Y]  - ADAMS M W, "D-ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE (EASTMAN VITAMI E TPGS) AS AN EMULSIFIER AND BIOENHANCER FOR DRUGS AND LIPOPHILIC COMPOUNDS", INTERNATIONAL CONGRESS OF TECHNOLOGY AND PHARMACOLOGY, ASSOC. PHARM. GALENIQUE IND., CHATENAY MALABRY, FR, (1992), pages 254 - 262, XP000576964 [Y] 1-8 * page 261, paragraph 4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.